LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA
Clinical trials for LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets tough breast cancer in phase II trial
Disease control OngoingThis study tests whether a drug called olaparib (a PARP inhibitor) works better alone or combined with atezolizumab (an immunotherapy) for people with advanced non-HER2-positive breast cancer that has a BRCA mutation. About 81 participants with locally advanced or metastatic dise…
Matched conditions: LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:15 UTC
-
New drug combo shows promise in Hard-to-Treat breast cancer
Disease control OngoingThis early-phase trial tested a combination of two drugs—low-dose cyclophosphamide and veliparib—in 35 people with HER2-negative breast cancer that had spread or couldn't be removed by surgery. The goal was to find the safest dose and see if the combo could shrink tumors. While n…
Matched conditions: LOCALLY ADVANCED UNRESECTABLE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:14 UTC